An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few Everything You Need to Know About the FDA Peptide Ban Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives